Cormorant Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,175,000
| Closed | -$25.4M | – | 62 |
|
|
2023
Q4 | $25.4M | Buy |
+1,175,000
| New | +$25.4M | 1.21% | 24 |
|
|
2017
Q2 | – | Sell |
-240,403
| Closed | -$3.3M | – | 76 |
|
|
2017
Q1 | $3.3M | Hold |
240,403
| – | – | 0.48% | 48 |
|
|
2016
Q4 | $1.72M | Hold |
240,403
| – | – | 0.23% | 65 |
|
|
2016
Q3 | $3.65M | Buy |
240,403
+25,984
| +12% | +$394K | 0.4% | 59 |
|
|
2016
Q2 | $2.11M | Hold |
214,419
| – | – | 0.3% | 58 |
|
|
2016
Q1 | $2.86M | Buy |
+214,419
| New | +$2.86M | 0.43% | 54 |
|